DAFNA Capital Management LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 78 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.73 and the average weighting 0.4%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$530,000
-95.5%
150,000
-89.3%
0.54%
-95.2%
Q2 2014$11,700,000
+13.3%
1,401,146
-13.8%
11.09%
+25.0%
Q1 2014$10,323,000
+240.1%
1,625,703
+281.9%
8.87%
+184.0%
Q4 2013$3,035,000
-4.9%
425,7030.0%3.12%
-10.4%
Q3 2013$3,193,000425,7033.49%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Shilanski & Associates, Inc. 937,237$57,0000.02%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$57,0000.02%
CVA Family Office, LLC 1,137,920$69,0000.02%
Cypress Capital Management LLC (WY) 140,925$9,0000.01%
Helen Stephens Group, LLC 117,222$7,0000.01%
COURIER CAPITAL LLC 540,056$33,0000.00%
NORTHCAPE WEALTH MANAGEMENT, LLC 98,000$6,0000.00%
Newbridge Financial Services Group, Inc. 10,000$1,0000.00%
Western Wealth Management, LLC 352,950$11,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 606,800$37,0000.00%
View complete list of AMPIO PHARMACEUTICALS INC shareholders